In standard functional assays, orforglipron shows greater than 100-fold selectivity for the GLP-1 receptor over the glucagon receptor, the GIP receptor, and the secretin receptor
The study also aimed to determine the risk of gastrointestinal adverse events, risk for discontinuation and serious adverse events after treatment with semaglutide
As owners spend more on premium food, supplements, diagnostics and veterinary treatments, its creating new opportunities for biotech alongside traditional pet-food companies
PET evidence for reduced alcohol-induced dopamine release after naltrexone
Zhu Y, Pandya BJ, Choi HK
Andy Schmelz, an associate professor of pharmacy practice at Butler University, explained how GLP-1s work